Literature DB >> 25016225

Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.

Sílvia Vilarinho1, E Zeynep Erson-Omay2, Akdes Serin Harmanci2, Raffaella Morotti3, Geneive Carrion-Grant2, Jacob Baranoski2, A S Knisely4, Udeme Ekong5, Sukru Emre6, Katsuhito Yasuno2, Kaya Bilguvar2, Murat Günel7.   

Abstract

Hepatocellular carcinoma (HCC) rarely occurs in childhood. We describe a patient with new onset of pruritus at 8 months of age who at 17 months of age was found to have a 2.5 cm HCC. To delineate the possible genetic basis of this tumour, we performed whole exome sequencing (WES) of the germline DNA and identified two novel predictably deleterious missense mutations in ABCB11, encoding bile salt export pump (BSEP), confirmed in the parental DNA as bi-allelic and inherited. Although inherited ABCB11 mutations have previously been linked to HCC in a small number of cases, the molecular mechanisms of hepatocellular carcinogenesis in ABCB11 disease are unknown. WES of the HCC tissue uncovered somatic driver mutations in the beta-catenin (CTNNB1) and nuclear-factor-erythroid-2-related-factor-2 (NFE2L2) genes. Moreover, clonality analysis predicted that the CTNNB1 mutation was clonal and occurred earlier during carcinogenesis, whereas the NFE2L2 mutation was acquired later. Interestingly, background liver parenchyma showed no inflammation or fibrosis and BSEP expression was preserved. This is the first study to identify somatic CTNNB1 and NFE2L2 mutations in early childhood arisen in the setting of inherited bi-allelic ABCB11 mutations. Rapid WES analysis expedited this child's diagnosis and treatment, and likely improved her prognosis.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABCB11 mutations; CTNNB1; NFE2L2; Paediatric hepatocellular carcinoma; Whole exome sequencing

Mesh:

Substances:

Year:  2014        PMID: 25016225     DOI: 10.1016/j.jhep.2014.07.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Exome Sequencing in Clinical Hepatology.

Authors:  Sílvia Vilarinho; Pramod K Mistry
Journal:  Hepatology       Date:  2019-12       Impact factor: 17.425

2.  Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency.

Authors:  Mukul Vij; Naresh P Shanmugam; Mettu Srinivas Reddy; Srinivas Sankaranarayanan; Mohamed Rela
Journal:  Virchows Arch       Date:  2017-07-21       Impact factor: 4.064

3.  Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.

Authors:  Sílvia Vilarinho; E Zeynep Erson-Omay; Kisha Mitchell-Richards; Charles Cha; Carol Nelson-Williams; Akdes Serin Harmancı; Katsuhito Yasuno; Murat Günel; Tamar H Taddei
Journal:  J Hepatol       Date:  2017-03-18       Impact factor: 25.083

4.  ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Authors:  Sílvia Vilarinho; Sinan Sari; Francesca Mazzacuva; Kaya Bilgüvar; Güldal Esendagli-Yilmaz; Dhanpat Jain; Gülen Akyol; Buket Dalgiç; Murat Günel; Peter T Clayton; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

5.  Clinical utility of genomic analysis in adults with idiopathic liver disease.

Authors:  Aaron Hakim; Xuchen Zhang; Angela DeLisle; Elif A Oral; Daniel Dykas; Kaela Drzewiecki; David N Assis; Marina Silveira; Jennifer Batisti; Dhanpat Jain; Allen Bale; Pramod K Mistry; Silvia Vilarinho
Journal:  J Hepatol       Date:  2019-04-15       Impact factor: 25.083

6.  Hepatocellular carcinoma associated with tight-junction protein 2 deficiency.

Authors:  Shengmei Zhou; Paula M Hertel; Milton J Finegold; Larry Wang; Nanda Kerkar; Jing Wang; Lee-Jun C Wong; Sharon E Plon; Melissa Sambrotta; Pierre Foskett; Zhiyv Niu; Richard J Thompson; A S Knisely
Journal:  Hepatology       Date:  2015-06-19       Impact factor: 17.425

7.  Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.

Authors:  Junyan Tao; Yekaterina Krutsenko; Akshata Moghe; Sucha Singh; Minakshi Poddar; Aaron Bell; Michael Oertel; Aatur D Singhi; David Geller; Xin Chen; Amaia Lujambio; Silvia Liu; Satdarshan P Monga
Journal:  Hepatology       Date:  2021-06-21       Impact factor: 17.298

Review 8.  Structural and functional hepatocyte polarity and liver disease.

Authors:  Paul Gissen; Irwin M Arias
Journal:  J Hepatol       Date:  2015-06-24       Impact factor: 25.083

9.  Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.

Authors:  Surbhi Chouhan; Snahlata Singh; Dipti Athavale; Pranay Ramteke; Vimal Pandey; Jomon Joseph; Rajashekar Mohan; Praveen Kumar Shetty; Manoj Kumar Bhat
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

Review 10.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.